This review provides an overview of the definition, risk stratification, pathogenesis, diagnostic approach, and management of pulmonary embolism, emphasizing the importance of risk stratification and aggressive measures for massive pulmonary embolism.
Reinforces emphasis on risk stratification for massive PE; leaves open optimal aggressive strategies pending prospective trials.
Pulmonary embolism covers a wide spectrum of presentation from an asymptomatic individual to a life-threatening medical emergency. It is of paramount importance to appropriately risk stratify patients with pulmonary embolism, particularly with those who present without hypotension. Right ventricular dysfunction can evolve after a patient has received a diagnosis of pulmonary embolism, necessitating aggressive measures rather than simple anticoagulation. In this review, we discuss definition, risk stratification, pathogenesis, diagnostic approach, and management, with particular focus on massive pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Rali et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: